Editorial: Metabolic cell death in cancer: innovative therapeutic avenues for cancer treatment - Top-Institutions - MDSpire

Editorial: Metabolic cell death in cancer: innovative therapeutic avenues for cancer treatment

  • By

  • Zhou Yang

  • Guang Lei

  • Yize Li

  • June 9, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Oncology

  • #4

    Shanghai Children's Medical Center
    Shanghai Children's Medical Center

    Shanghai, China

    Key Differentiators

    • Pediatric Oncology

  • #5

    University of Massachusetts Amherst
    University of Massachusetts Amherst

    Amherst, Massachusetts

    Key Differentiators

    • Biomedical Engineering

Original Source(s)

Editorial: Metabolic cell death in cancer: innovative therapeutic avenues for cancer treatment

  • by Zhou Yang, Guang Lei, Yize Li

  • June 9, 2026

Related Content

Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer

First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial

Digital Twins as catalysts for Whole Person Health Mind Body Medicine in Integrative Oncology